Explicit|19|38|189..196|1,1|earlier|||earlier|||Temporal.Asynchronous.Succession||||Wr|Comm|Null|Null||||9..171|0|Ciba-Geigy Ltd. and Chiron Corp. said they extended their offer for Connaught BioSciences Inc., valued at 866 million Canadian dollars (US$736 million) to Oct. 27|Inh|Null|Null|Null||||175..188;197..319|1,0;1,2;1,3|The companies said they didn't want to raise their offer to match a rival bid by Institut Merieux S.A. of C$37 a share, or C$942 million|Inh|Null|Null|Null|||||||||
Explicit|19|38|321..324|2,0|But|||but|||Comparison.Contrast||||Wr|Comm|Null|Null||||202..319|1,2,1|they didn't want to raise their offer to match a rival bid by Institut Merieux S.A. of C$37 a share, or C$942 million|Ot|Comm|Null|Null|175..201|1,0;1,1;1,2,0;1,3|The companies earlier said|335..420|2,2,1|the C$30-a-share bid, which was due to expire Monday, may still be extended or varied|Ot|Comm|Null|Null|325..334|2,1;2,2,0;2,3|they said||||||
Explicit|19|38|393..398|2,2,1,1,1,1|still|||still|||Comparison.Contrast.Opposition||||Ot|Comm|Null|Null|325..334|2,1;2,2,0;2,3|they said|357..387|2,2,1,1,0,2|which was due to expire Monday|Inh|Null|Null|Null||||335..355;389..392;399..420|2,2,1,0;2,2,1,1,0,0;2,2,1,1,0,1;2,2,1,1,0,3;2,2,1,1,1,0;2,2,1,1,1,2|the C$30-a-share bid may be extended or varied|Inh|Null|Null|Null|||||||||
Implicit|19|38||||532|4||while||Comparison.Contrast.Juxtaposition||||Wr|Comm|Null|Null||||424..530|3|Merieux, a vaccine manufacturer based in Lyon, France, is 51%-held by French state-owned Rhone-Poulenc S.A|Inh|Null|Null|Null||||532..604|4|Ciba-Geigy is a major pharmaceutical concern based in Basel, Switzerland|Inh|Null|Null|Null|||||||||
Implicit|19|38||||606|5||and||Expansion.Conjunction||||Wr|Comm|Null|Null||||532..604|4|Ciba-Geigy is a major pharmaceutical concern based in Basel, Switzerland|Inh|Null|Null|Null||||606..675|5|Chiron, another pharmaceutical concern, is based in Emeryville, Calif|Inh|Null|Null|Null|||||||||
Implicit|19|38||||677|6||and||Expansion.Conjunction||||Wr|Comm|Null|Null||||532..675|4;5|Ciba-Geigy is a major pharmaceutical concern based in Basel, Switzerland.Chiron, another pharmaceutical concern, is based in Emeryville, Calif|Inh|Null|Null|Null||||677..748|6|Connaught is a biotechnology research and vaccine manufacturing concern|Inh|Null|Null|Null|||||||||
Implicit|19|38||||976|8||consequently||Contingency.Cause.Result||||Wr|Comm|Null|Null||||752..853|7,0;7,1,0;7,1,1,0;7,1,1,1,0;7,1,1,1,1,0;7,1,1,1,1,1,0;7,1,1,1,1,1,1,0;7,1,1,1,1,1,1,1;7,2|Institut Merieux's bid for Toronto-based Connaught has run into problems with the Canadian government|Inh|Null|Null|Null||||976..1077|8|Merieux officials are expected to meet with federal officials in Ottawa today to discuss the decision|Inh|Null|Null|Null|||||||||
